NOT FOR DISTRIBUTION
Header cover image

Market Cap

CHF2.2b

Last Updated

2021/05/13 01:03 UTC

Data Sources

Company Financials +

Executive Summary

Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. More Details


Snowflake Analysis

Solid track record with high growth potential.


Similar Companies

Share Price & News

How has Medacta Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MOVE is more volatile than 75% of Swiss stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: MOVE's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of Swiss stocks.


Market Performance


7 Day Return

0.2%

MOVE

-2.9%

CH Medical Equipment

-1.1%

CH Market


1 Year Return

53.4%

MOVE

37.9%

CH Medical Equipment

17.0%

CH Market

Return vs Industry: MOVE exceeded the Swiss Medical Equipment industry which returned 33.7% over the past year.

Return vs Market: MOVE exceeded the Swiss Market which returned 14.6% over the past year.


Shareholder returns

MOVEIndustryMarket
7 Day0.2%-2.9%-1.1%
30 Day3.9%-2.8%-1.6%
90 Day6.9%3.4%1.9%
1 Year53.4%53.4%38.9%37.9%20.6%17.0%
3 Yearn/a67.5%60.6%28.6%13.9%
5 Yearn/a147.5%129.7%59.8%30.4%

Long-Term Price Volatility Vs. Market

How volatile is Medacta Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Medacta Group undervalued compared to its fair value and its price relative to the market?

1.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MOVE (CHF111.2) is trading below our estimate of fair value (CHF112.27)

Significantly Below Fair Value: MOVE is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: MOVE is good value based on its PE Ratio (54.6x) compared to the Swiss Medical Equipment industry average (62x).

PE vs Market: MOVE is poor value based on its PE Ratio (54.6x) compared to the Swiss market (24.3x).


Price to Earnings Growth Ratio

PEG Ratio: MOVE is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: MOVE is overvalued based on its PB Ratio (12.3x) compared to the CH Medical Equipment industry average (6x).


Future Growth

How is Medacta Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

22.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MOVE's forecast earnings growth (22.8% per year) is above the savings rate (-0.3%).

Earnings vs Market: MOVE's earnings (22.8% per year) are forecast to grow faster than the Swiss market (12.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MOVE's revenue (13% per year) is forecast to grow faster than the Swiss market (4.5% per year).

High Growth Revenue: MOVE's revenue (13% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MOVE's Return on Equity is forecast to be high in 3 years time (24.1%)


Past Performance

How has Medacta Group performed over the past 5 years?

-19.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MOVE has high quality earnings.

Growing Profit Margin: MOVE's current net profit margins (12.3%) are higher than last year (3.8%).


Past Earnings Growth Analysis

Earnings Trend: MOVE's earnings have declined by 19.7% per year over the past 5 years.

Accelerating Growth: MOVE's earnings growth over the past year (213%) exceeds its 5-year average (-19.7% per year).

Earnings vs Industry: MOVE earnings growth over the past year (213%) exceeded the Medical Equipment industry -46.3%.


Return on Equity

High ROE: MOVE's Return on Equity (22.5%) is considered high.


Financial Health

How is Medacta Group's financial position?


Financial Position Analysis

Short Term Liabilities: MOVE's short term assets (€217.7M) exceed its short term liabilities (€144.8M).

Long Term Liabilities: MOVE's short term assets (€217.7M) exceed its long term liabilities (€132.4M).


Debt to Equity History and Analysis

Debt Level: MOVE's debt to equity ratio (79.8%) is considered high.

Reducing Debt: Insufficient data to determine if MOVE's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: MOVE's debt is well covered by operating cash flow (45.4%).

Interest Coverage: MOVE's interest payments on its debt are well covered by EBIT (18.2x coverage).


Balance Sheet


Dividend

What is Medacta Group current dividend yield, its reliability and sustainability?

0.84%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MOVE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MOVE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MOVE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MOVE's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MOVE's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.8yrs

Average management tenure


CEO

Francesco Siccardi (43 yo)

2.5yrs

Tenure

Dr. Francesco Siccardi has been Chief Executive Officer of Medacta Group SA since November 1, 2018. He is a Member of the Board of Directors of Surgical Practice Resource Group SA, Lugano since 2015 and of...


Leadership Team

Experienced Management: MOVE's management team is seasoned and experienced (7.8 years average tenure).


Board Members

Experienced Board: MOVE's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Medacta Group SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Medacta Group SA
  • Ticker: MOVE
  • Exchange: SWX
  • Founded: 1958
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CHF2.224b
  • Shares outstanding: 20.00m
  • Website: https://www.medacta.com

Number of Employees


Location

  • Medacta Group SA
  • Strada Regina, 34
  • Castel San Pietro
  • Ticino
  • 6874
  • Switzerland

Listings


Biography

Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic mode...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/13 01:03
End of Day Share Price2021/05/12 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.